1. Polito C, Apicella A, Marte A, Signoriello G, La Manna A. Clinical presentation and metabolic features of overt and occult urolithiasis. Pediat Nephrol 2012;27(1):101-7. [
DOI:10.1007/s00467-011-1940-8] [
PMID]
2. La Manna A, Polito C, Cioce F, De Maria G, Capacchione A, Rocco CE, et al. Calyceal microlithiasis in children: report on 196 cases. Pediat Nephrol 1998;12(3):214-7. [
DOI:10.1007/s004670050440] [
PMID]
3. Polito C, La Manna A, Cioce F, Villani J, Nappi B, Di Toro R. Clinical presentation and natural course of idiopathic hypercalciuria in children. Pediat Nephrol 2000;15(3-4):211-4. [
DOI:10.1007/s004670000433] [
PMID]
4. Bilge I, Yilmaz A, Kayiran SM, Emre S, Kadioglu A, Yekeler E, et al. Clinical importance of renal calyceal microlithiasis in children. Pediat Int 2013;55(6):731-6. [
DOI:10.1111/ped.12186] [
PMID]
5. Matlaga BR, Schaeffer AJ, Novak TE, Trock BJ. Epidemiologic insights into pediatric kidney stone disease. Urol Res 2010;38(6):453-7. [
DOI:10.1007/s00240-010-0327-9] [
PMID]
6. Fallahzadeh MH, Zare J, Hosseini AHG, Derakhshan A, Basiratnia M, Arasteh MM, et al. Elevated serum levels of Vitamin D in infants with urolithiasis. Iran J Kidney Dis 2012;6(3):186-91. [
Google Scholar]
7. VanDervoort K, Wiesen J, Frank R, Vento S, Crosby V, Chandra M, et al. Urolithiasis in pediatric patients: a single center study of incidence, clinical presentation and outcome. J Urol 2007;177(6):2300-5. [
DOI:10.1016/j.juro.2007.02.002] [
PMID]
8. van't Hoff WG. Aetiological factors in paediatric urolithiasis. Nephron Clin Pract 2004;98(2):c45-c8. [
DOI:10.1159/000080251] [
PMID]
9. Alpay H, Ozen A, Gokce I, Biyikli N. Clinical and metabolic features of urolithiasis and microlithiasis in children. Pediat Nephrol 2009;24(11):2203. [
DOI:10.1007/s00467-009-1231-9] [
PMID]
10. Mousavi Jazayeri SM, Pourmoghaddam A, Emam SJ. Microlithiasis and Nephrolithiasis among infants: Is it a new phenomenon?. Pakistan J Med Sci 2011;27(1). [
URL]
11. Kelsoe J, Greenwood T, Akiskal H, Akiskal K. The genetic basis of affective temperament and the bipolar spectrum. Int Clin Psychopharmacol 2012;28:e5-e6. [
DOI:10.1097/01.yic.0000423231.81230.9e]
12. Bartosh SM. Medical management of pediatric stone disease. Urologic Clin North America 2004;31(3):575-87. [
DOI:10.1016/j.ucl.2004.04.005] [
PMID]
13. Eshed I, Witzling M. The role of unenhanced helical CT in the evaluation of suspected renal colic and atypical abdominal pain in children. Pediatr Radiol 2002;32(3):205-8. [
DOI:10.1007/s00247-001-0610-6] [
PMID]
14. Malaki M. The comparison of ultrasound and non-contrast helical computerized tomography for children nephrolithiasis detection. Urology Annal 2014;6(4):309. [
DOI:10.4103/0974-7796.140991] [
PMID] [
PMCID]
15. Polito C, Cioce F, La Manna A, Maiello R, Di Toro R. Renal calyceal microlithiasis: clinical presentation may precede sonographic evidence. Clin Pediatr 1999;38(9):521-4. [
DOI:10.1177/000992289903800904] [
PMID]
16. Spivacow FR, Negri AL, Polonsky A, Del Valle EE. Long-term treatment of renal lithiasis with potassium citrate. Urology 2010;76(6):1346-9. [
DOI:10.1016/j.urology.2010.02.029] [
PMID]
17. Barcelo P, Wuhl O, Servitge E, Rousaud A, Pak C. Randomized double-blind study of potassium citrate in idiopathic hypocitraturic calcium nephrolithiasis. J Urology 1993;150(6):1761-4. [
DOI:10.1016/S0022-5347(17)35888-3]
18. Ettinger B, Pak CY, Citron JT, Thomas C, Adams-Huet B, Vangessel A. Potassiummagnesium citrate is an effective prophylaxis against recurrent calcium oxalate nephrolithiasis. J Urology 1997;158(6):2069-73. [
DOI:10.1016/S0022-5347(01)68155-2]
19. Zmonarski S, Klinger M, Puziewicz-Zmonarska A, Krajewska M, Mazanowska O, Dembińska E. Therapeutic use of potassium citrate. Przeglad lekarski 2001;58(2):82. [
Google Scholar]
20. Tekin A, Tekgul S, Atsu N, Bakkaloglu M, Kendi S. Oral potassium citrate treatment for idiopathic hypocitruria in children with calcium urolithiasis. J Urology 2002;168(6):2572-4.
https://doi.org/10.1016/S0022-5347(05)64218-8 [
DOI:10.1097/00005392-200212000-00076]
21. Sorkhi H, Saeedizand N, Poornasrollah M, Bijani A, Shafi H. Efficacy of potassium polycitrate on renal stone and microlithiasis predisposed by metabolic disorders. Caspian J Inter Med 2017;8(4):296. [
PMID] [
PMCID]
22. Soygür T, Akbay A, Küpeli S. Effect of potassium citrate therapy on stone recurrence and residual fragments after shockwave lithotripsy in lower caliceal calcium oxalate urolithiasis: a randomized controlled trial. J Endourol 2002;16(3):149-52. [
DOI:10.1089/089277902753716098] [
PMID]
23. Reddy S, Shaik AB, Bokkisam S. Effect of potassium magnesium citrate and vitamin B-6 prophylaxis for recurrent and multiple calcium oxalate and phosphate urolithiasis. Korean J Urolog 2014;55(6):411-6. [
DOI:10.4111/kju.2014.55.6.411] [
PMID] [
PMCID]
24. Güven AG, Koyun M, Baysal YE, Akman S, Alimoglu E, Akbas H, et al. Urolithiasis in the first year of life. Pediat Nephrol 2010;25(1):129. [
DOI:10.1007/s00467-009-1296-5] [
PMID]
25. Mokhless IA, Sakr MA, Abdeldaeim HM, Hashad MM. Radiolucent renal stones in children: combined use of shock wave lithotripsy and dissolution therapy. Urology 2009;73(4):772-5. [
DOI:10.1016/j.urology.2008.10.066] [
PMID]
26. Hosking DH, Erickson SB, Van Den Berg CJ, Wilson DM, Smith LH. The stone clinic effect in patients with idiopathic calcium urolithiasis. J Urology 1983;130(6):1115-8. [
DOI:10.1016/S0022-5347(17)51711-5]
27. Mohammadjafari H, Kosaryan M, Tahernassab Z. Efficacy of Potassium Citrate in Treatment of Nephrolithiasis Less Than 7mm Diameter in Children without Any Metabolic or Infectious Risk Factors. J Mazandaran Univ Med Sci 2017;27(152):40-9. [
Google Scholar]
28. Tasian GE, Copelovitch L. Evaluation and medical management of kidney stones in children. J Urology 2014;192(5):1329-36. [
DOI:10.1016/j.juro.2014.04.108] [
PMID]
29. Fallahzadeh MA, Hassanzadeh J, Fallahzadeh MH. What do we know about pediatric renal microlithiasis? J Renal Injury Prevent 2017;6(2):70. [
DOI:10.15171/jrip.2017.13] [
PMID] [
PMCID]
30. Mohammadjafari H, Barzin M, Salehifar E, Kord MK, Aalaee A, Mohammadjafari R. Etiologic and epidemiologic pattern of urolithiasis in north iran; review of 10-year findings. Iranian J Pediat 2014;24(1):69. [
PMID] [
PMCID]
31. Stoller ML, Chi T, Eisner BH, Shami G, Gentle DL. Changes in urinary stone risk factors in hypocitraturic calcium oxalate stone formers treated with dietary sodium supplementation. J Urology 2009;181(3):1140-4. [
DOI:10.1016/j.juro.2008.11.020] [
PMID]
32. Domrongkitchaiporn S, Stitchantrakul W, Kochakarn W. Causes of hypocitraturia in recurrent calcium stone formers: focusing on urinary potassium excretion. American J Kidney Dis 2006;48(4):546-54. [
DOI:10.1053/j.ajkd.2006.06.008] [
PMID]
33. Bozkurt HB, Çetin T, Sarıca K. The Possible Beneficial Effect of Breastfeeding on the Clinical Course of Urolithiasis Detected During Infancy. Breastfeed Med 2020;15(2):84-9. [
DOI:10.1089/bfm.2019.0236] [
PMID]
34. Elderwy AA, Kurkar A, Hussein A, Abozeid H, Hammodda HM, Ibraheim A-F. Dissolution therapy versus shock wave lithotripsy for radiolucent renal stones in children: a prospective study. J Urology 2014;191(5):1491-5 [
DOI:10.1016/j.juro.2013.10.060] [
PMID]